Pacylex Pharmaceuticals
PrivateLast Round
Grant
Jul 1, 2024
Total Funding Raised
$14.96M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pacylex Pharmaceuticals operates in Healthcare & Life Sciences and is based in Edmonton. Its latest recorded funding round was a Grant round in July 2024.
Pacylex Pharmaceuticals is a pharmaceutical company that develops N-myristoyltransferase inhibitors as targeted therapies for hematologic and solid cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pacylex Pharmaceuticals Comparables
Compare Pacylex Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SignalChem Lifesciences Corporation | 77% | |
| Novartis | 73% | |
| Orinove Inc. | 72% |
For institutional investors. Book with your work email.
Pacylex Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2024 | ||||
| Grant | Oct 12, 2022 | ||||
| Series A | Jun 2, 2021 | ||||
| Grant | Jun 1, 2020 | ||||
| Convertible Debt | Mar 4, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pacylex Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| Alberta Innovates | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 598% MoM.
- May 1, 2025
Monthly visitors increased 229% MoM.
For institutional investors. Book with your work email.
Pacylex Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pacylex Pharmaceuticals's valuation, stock price, and market status.
Is Pacylex Pharmaceuticals a public or private company?
Pacylex Pharmaceuticals is a private company.
What is the current stock price of Pacylex Pharmaceuticals?
Pacylex Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Pacylex Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pacylex Pharmaceuticals worth (valuation)?
Valuation information for Pacylex Pharmaceuticals is not publicly available.
Can I buy Pacylex Pharmaceuticals stock?
Pacylex Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pacylex Pharmaceuticals's last funding round?
Pacylex Pharmaceuticals's most recent funding round was Grant on July 1, 2024.
Who are the main investors in Pacylex Pharmaceuticals?
Key investors in Pacylex Pharmaceuticals include United States Department of Defense, Alberta Innovates.
Will Pacylex Pharmaceuticals IPO soon?
No public IPO plans have been announced for Pacylex Pharmaceuticals.
How can I track Pacylex Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Pacylex Pharmaceuticals's shares on secondary markets.